SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Celldex Therapeutics, Inc.'s CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer Expressing Elevated Levels of GPNMB and in Triple Negative Disease